Department of Physical Medicine and Rehabilitation, University of Rochester Medical Center, Rochester, NY.
Department of Physical Medicine and Rehabilitation, University of Rochester Medical Center, Rochester, NY.
Arch Phys Med Rehabil. 2022 Dec;103(12):2311-2315. doi: 10.1016/j.apmr.2022.03.016. Epub 2022 Apr 13.
To investigate the ability of Patient-Reported Outcomes Measurement Information System (PROMIS) to capture the therapeutic effect of first-time medial branch radiofrequency ablation (RFA).
Before-after trial.
Single academic spine center.
Patients who underwent first-time medial branch RFA for lumbar facet joint pain identified by dual comparative medial branch block with ≥80% pain relief between January 1, 2015 and September 1, 2019 were identified using procedural billing codes. Charts were reviewed manually to confirm accuracy and strict adherence to the 80% pain relief threshold for each medial branch block. Thirty-nine patients met the criteria and were included in this study (N=39).
Medial branch RFA.
PROMIS score domains of Depression, Pain Interference, and Physical Function collected pre- and post RFA were compared. Pretreatment scores were within 6 weeks prior to the first medial branch block. Posttreatment scores were between 5 weeks and 6 months after RFA. Paired-sample t test analyses were used to calculate responsiveness to treatment, with significance assigned as P<.05 prior to acquiring data. Effect size was calculated using Cohen's d.
PROMIS domains of Pain Interference and Physical Function demonstrated a statistically significant improvement (P=.004 and P=.017, respectively). The PROMIS domain of Depression did not demonstrate a statistically significant change (P=.12). The effect size was medium (d=-0.43) for Pain Interference, small/medium (d=0.31) for Physical Function, and small (d=-0.12) for Depression.
Medial branch RFA as a treatment for lumbar facet syndrome is associated with a statistical improvement in PROMIS domains of Physical Function and Pain Interference.
研究患者报告结局测量信息系统(PROMIS)在首次内侧支射频消融(RFA)治疗中的疗效。
前后对照试验。
单学术脊柱中心。
2015 年 1 月 1 日至 2019 年 9 月 1 日,根据双侧对比内侧支阻滞术,采用程序计费代码,确定接受首次内侧支 RFA 治疗的单侧腰椎小关节疼痛患者。通过手工查阅图表,确认每例内侧支阻滞的准确性和 80%疼痛缓解率的严格标准。39 例患者符合标准并纳入本研究(N=39)。
内侧支 RFA。
比较 RFA 前后的 PROMIS 评分量表的抑郁、疼痛干扰和身体功能领域。治疗前评分在第一次内侧支阻滞前 6 周内,治疗后评分在 RFA 后 5 周至 6 个月之间。采用配对样本 t 检验分析治疗反应,在获取数据前,指定 P<.05 为具有统计学意义。采用 Cohen's d 计算效应大小。
疼痛干扰和身体功能的 PROMIS 量表域显示出统计学上的显著改善(P=.004 和 P=.017)。抑郁的 PROMIS 量表域没有显示出统计学上的显著变化(P=.12)。疼痛干扰的效应大小为中等(d=-0.43),身体功能的效应大小为小/中等(d=0.31),抑郁的效应大小为小(d=-0.12)。
内侧支 RFA 治疗腰椎小关节综合征与身体功能和疼痛干扰的 PROMIS 量表域的统计学改善相关。